PLGA microsphere-based composite hydrogel for dual delivery of ciprofloxacin and ginsenoside Rh2 to treat Staphylococcus aureus-induced skin infections
When antibiotic-resistant pathogenic bacteria pose a high threat to human health, bacterial multidrug efflux pumps become major contributors to the high-level antibiotic resistance in most microorganisms. Since traditional antibiotics are still indispensable currently, we report a dual drug delivery system to maximize the antibacterial efficacy of antibiotics by inhibiting efflux pumps in bacteria before their exposure to antibiotics. In this research, a microsphere/hydrogel composite was constructed from ciprofloxacin (Cip)-loaded poly (lactic-co-glycolic acid) (PLGA) microspheres and ginsenoside Rh2 (G-Rh2) dispersed thermo-sensitive hydrogel to treat skin infections. In vitro drug release studies indicated that while G-Rh2 in hydrogel presented a faster and short-term release manner to rapidly inhibit the NorA efflux pumps, Cip showed a sustained and long-term release behavior to provide a local high concentration gradient for facilitating drug percutaneous penetration. The combination of Cip and G-Rh2 demonstrated a high degree of synergism against both methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA), hence significantly improving their in vitro antibacterial activity and efficiency. Moreover, the antibacterial performance of the microsphere/hydrogel composite with a sequential release profile is superior to that of other formulations in mouse model of MRSA skin infections, indicating its great potential to treat antibiotic-resistant skin infections.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
---|---|
Enthalten in: |
Drug delivery - 27(2020), 1 vom: 20. Dez., Seite 632-641 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sun, Minghao [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 02.02.2021 Date Revised 23.04.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1080/10717544.2020.1756985 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM309137144 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM309137144 | ||
003 | DE-627 | ||
005 | 20231225133240.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/10717544.2020.1756985 |2 doi | |
028 | 5 | 2 | |a pubmed24n1030.xml |
035 | |a (DE-627)NLM309137144 | ||
035 | |a (NLM)32329376 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sun, Minghao |e verfasserin |4 aut | |
245 | 1 | 0 | |a PLGA microsphere-based composite hydrogel for dual delivery of ciprofloxacin and ginsenoside Rh2 to treat Staphylococcus aureus-induced skin infections |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.02.2021 | ||
500 | |a Date Revised 23.04.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a When antibiotic-resistant pathogenic bacteria pose a high threat to human health, bacterial multidrug efflux pumps become major contributors to the high-level antibiotic resistance in most microorganisms. Since traditional antibiotics are still indispensable currently, we report a dual drug delivery system to maximize the antibacterial efficacy of antibiotics by inhibiting efflux pumps in bacteria before their exposure to antibiotics. In this research, a microsphere/hydrogel composite was constructed from ciprofloxacin (Cip)-loaded poly (lactic-co-glycolic acid) (PLGA) microspheres and ginsenoside Rh2 (G-Rh2) dispersed thermo-sensitive hydrogel to treat skin infections. In vitro drug release studies indicated that while G-Rh2 in hydrogel presented a faster and short-term release manner to rapidly inhibit the NorA efflux pumps, Cip showed a sustained and long-term release behavior to provide a local high concentration gradient for facilitating drug percutaneous penetration. The combination of Cip and G-Rh2 demonstrated a high degree of synergism against both methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA), hence significantly improving their in vitro antibacterial activity and efficiency. Moreover, the antibacterial performance of the microsphere/hydrogel composite with a sequential release profile is superior to that of other formulations in mouse model of MRSA skin infections, indicating its great potential to treat antibiotic-resistant skin infections | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Ciprofloxacin | |
650 | 4 | |a ginsenoside Rh2 | |
650 | 4 | |a microsphere/hydrogel composite | |
650 | 4 | |a sequential release | |
650 | 4 | |a skin infections | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Ginsenosides |2 NLM | |
650 | 7 | |a Hydrogels |2 NLM | |
650 | 7 | |a Polylactic Acid-Polyglycolic Acid Copolymer |2 NLM | |
650 | 7 | |a 1SIA8062RS |2 NLM | |
650 | 7 | |a Ciprofloxacin |2 NLM | |
650 | 7 | |a 5E8K9I0O4U |2 NLM | |
650 | 7 | |a ginsenoside Rh2 |2 NLM | |
650 | 7 | |a 78214-33-2 |2 NLM | |
700 | 1 | |a Zhu, Chune |e verfasserin |4 aut | |
700 | 1 | |a Long, Jieyu |e verfasserin |4 aut | |
700 | 1 | |a Lu, Chao |e verfasserin |4 aut | |
700 | 1 | |a Pan, Xin |e verfasserin |4 aut | |
700 | 1 | |a Wu, Chuanbin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Drug delivery |d 1996 |g 27(2020), 1 vom: 20. Dez., Seite 632-641 |w (DE-627)NLM09361134X |x 1521-0464 |7 nnns |
773 | 1 | 8 | |g volume:27 |g year:2020 |g number:1 |g day:20 |g month:12 |g pages:632-641 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/10717544.2020.1756985 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 27 |j 2020 |e 1 |b 20 |c 12 |h 632-641 |